Aerin Medical

Aerin Medical

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://www.aerinmedical.com

Last Round

VC Round

Jan 13, 2025

Total Funding Raised

$71.2M

Momentum Score

25 /100

Company Overview

Aerin Medical is a medical device company that develops non-invasive therapeutic devices designed to enhance nasal breathing and address chronic nasal airway conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

nasal airway obstructionchronic rhinitistemperature-controlled RFENT devicesVivAerRhinAernon-invasive procedurein-office procedureradiofrequency treatmentear, nose, and throatENTmedtechnasal tissue remodelingradiofrequency ablationnasal surgery alternativeRF device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aerin Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aerin Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 13, 2025
DebtJan 13, 2025
VC RoundJun 16, 2022
VC RoundAug 17, 2020
DebtMay 21, 2019
Series C
Mar 22, 2016

Key People

Founding team and executive leadership

Derrick Sung

Chief Financial Officer

Executive Team

Aerin Medical Investors

Notable investors and investment history

InvestorRounds
KCK MedTechVC Round
Ally Bridge GroupVC Round
Questa CapitalVC Round
OrbiMedVC Round
Ares ManagementVC Round, Debt
KCK FZESeries C, VC Round
CRGDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 24, 2025

    Launched next-generation RhinAer for chronic rhinitis treatment.

  • Jan 13, 2025

    Completed a debt financing round.

Aerin Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aerin Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aerin Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMountain View, California
Employee Range169
Year Founded2011
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.